Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00613886 · ClinicalTrials.gov registry record · NA
Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus
A NA study, sponsored by University of California, Irvine.
- Terminated
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00613886 is a NA study that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 24 participants.
The verdict
NCT00613886, a NA study, was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The research project is designed to determine which combination of tests will enable physicians to predict whether a patient with symptoms of normal pressure hydrocephalus (NPH) will improve with a shunt.
Interventions
- DEVICE Programmable Shunt Insertion (Codman, Medtronic)
- BEHAVIORAL Assessments in physical therapy, occupational therapy, and speech therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00613886
The ClinicalTrials.gov registry entry for NCT00613886 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Programmable Shunt Insertion (Codman, Medtronic) is the first listed.
NCT00613886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00613886 about?
NCT00613886 is a clinical study titled "Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus". The research project is designed to determine which combination of tests will enable physicians to predict whether a patient with symptoms of normal pressure hydrocephalus (NPH) will improve with a shunt.
What is the current status of trial NCT00613886?
This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2006-03. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00613886?
The interventions under investigation include: Programmable Shunt Insertion (Codman, Medtronic) (DEVICE), Assessments in physical therapy, occupational therapy, and speech therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00613886?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.